E-cigarettes a Legitimate Tool for Smoking Cessation: Study

Aug.25.2022
E-cigarettes a Legitimate Tool for Smoking Cessation: Study
Australian study finds that e-cigarettes are a legitimate tool for adult smokers to quit smoking.

An Australian research team has extracted data from the 2019 National Drug Strategy Household Survey and analyzed the relationship between 3,868 adult smokers in Australia who use e-cigarettes and smoking cessation. The conclusion drawn is that e-cigarettes are a legitimate smoking cessation tool for adult smokers.


A recent study suggests that daily smokers are more likely to reduce their cigarette intake and quit smoking altogether compared to those who do not use e-cigarettes. Smokers over the past year are also more likely to quit smoking. However, occasional reduction of e-cigarette use and quitting smoking show no significant difference from those who do not use e-cigarettes.


Despite Australia's hostile attitude towards electronic cigarettes, in 2020, the Royal Australian College of General Practitioners (RACGP) announced its recommendation to use nicotine-containing electronic cigarette products for smoking cessation.


In the latest update of the national smoking cessation guidelines, general practitioners have stated that they have been conducting thorough reviews of the effectiveness and safety of e-cigarettes and have concluded that they are a legitimate cessation aid for adult smokers.


Last year, the recommendation to continue banning the importation of any nicotine-containing e-cigarette oil by Australian Federal Health Minister Greg Hunt was overlooked. Several months later, the Therapeutic Goods Administration (TGA) announced their final decision: "Importing nicotine e-cigarettes requires a doctor's prescription.


As of October 2021, Australia only allows the purchase of e-cigarette products from pharmacies through a prescription. While neighboring New Zealand and most other countries allow retailers to sell nicotine products over-the-counter, anyone found violating Australia's strict regulations will face hefty fines and, in some cases, even imprisonment.


A spokesperson for the TGA explained that such criminal offenses could result in civil penalties and fines, with individuals facing a maximum fine of 5,000 penalty units, equating to a maximum of $111,000, and companies facing a maximum fine of 50,000 penalty units, equating to a maximum of $11.1 million.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS and the company is unable to confirm the authenticity and accuracy of its content. The compilation of this article is intended for industry discussion and research purposes only.


Due to limitations in the level of translation, the translated article may not fully convey the meaning of the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in relation to any domestic, Hong Kong, Macao, Taiwan and foreign-related remarks and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
2Firsts found that U.S.-facing and cross-border vape retailer Vapesourcing has created a product page for the “RELX Creator Pro 15K Disposable Vape Kit 3%,” marked as “Coming Soon.” The page lists U.S. warehouse shipping options, but does not show that the product is currently available for purchase.
Market
Jun.08
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15